Honolulu, Hawaiʻi

Electrome Corporation

Electrome is headquartered in Honolulu, Hawaiʻi, on the island of Oʻahu. Hawaiʻi is an especially fitting home for our work: a cultural and geographic crossroads where Eastern healing traditions and Western medicine meet.

ASIAAMERICASHONOLULU
Honolulu, Oʻahu, Hawaiʻi21.31° N · 157.86° W

From Honolulu, we are building an AI-native platform for bioelectric medicine. Our commercial foundation begins with FDA-cleared devices for pain; our human-led Discovery R&D layer connects evidence, modeling, experiments, validation, and documentation.

FDA-cleared foundationAI-native · human-in-the-loopBioelectric medicineHeadquartered in Honolulu
Meet Electrome

Meet Electrome

Who we are, why bioelectric medicine starts with pain, and how ActiPatch® fits into the larger Electrome platform, told by the team.

Company film, v6 cut, November 2026. 4:07. English captions available in the player.

Powered by

Electrome

The therapeutic infrastructure layer for bioelectric medicine. FDA-cleared today, programmable for what comes next.

FDA 510(k) ClearedClinically StudiedImmediate Commercial Entry30+ Peer-Reviewed Studies
The Signal

What if the next breakthrough in medicine isn't a molecule, but a frequency?

Every living system runs on a hidden electrical operating system that governs healing, inflammation, immunity, and regeneration. Electrome is decoding that language and turning it into precision therapies.

Mission

Build bioelectric medicine from evidence to validation.

We begin with an FDA-cleared commercial foundation in pain, then apply AI-native Discovery R&D to organize evidence, challenge hypotheses, model signals, and support controlled scientific experiments. Scientists and appropriate regulatory pathways determine what can responsibly move forward.

Our approach

Three connected parts: research, devices, and care.

Three integrated pillars connect discovery, controlled laboratory work, and future translation. Evidence and wet-lab data inform exploratory AI-assisted modeling; scientists review the results; validated programs follow the appropriate scientific and regulatory pathway.

Discovery Engine

AI-guided mapping of the electrome, decoding how signal profiles modulate ion channels, membrane potentials, and inflammatory pathways across cell types.

Device Platform

Programmable applicator concepts in development, building on the FDA-cleared ActiPatch® foundation.

Clinical Integration

Research toward EHR-ready (FHIR) data workflows connecting devices, providers, and researchers.

MATRIX Platform Architecture

Electrome's AI-native Discovery R&D software pipeline and proposed MAT-based hardware vision. Hardware systems are conceptual and not cleared for medical, diagnostic, or therapeutic use.

MATRIX Discovery Software

Active AI-native R&D pipeline

Evidence
Human-led research inputs
Hypothesis
AI knowledge graph & matching
Model / Simulate
Computational simulation
Protocol / Experiment
Laboratory testing & operating models
Validate / Document
Data capture & verification
Learning feedback loop

MAT-Based MATRIX System

Proposed hardware vision (concept and design)

Future Research ConceptNot an existing clinical system. Not cleared for diagnostic or therapeutic use. Does not process live patient data.

Scan
Proposed sensing inputs
Diagnose
Future diagnostic research goal
Compute
AI parameter mapping
Proposed Closed Loop
Treat
Human authorizes every delivery
Measure
Proposed response measurement
Adapt
Reviewed adjustment within safety bounds
Treat again
Human authorizes subsequent pass
By the Numbers

Five decades of evidence. Built for scale.

30+
Peer-reviewed studies
50 yrs
Of bioelectric data
510(k)
FDA-cleared devices
AI
Native Discovery R&D
Research areas

Where we start, and where research may lead.

We start where the evidence is strongest: pain, inflammation, and wound healing. Concussion, infection, dementia, and oncology are longer-term research directions, not available treatments. Only pain devices are FDA cleared today.

Pain
Inflammation
Post Op Recovery
Wound Healing
Brain Injury
Infection
Oncology
Led by Proven Innovators

Trusted by the institutions advancing modern medicine.

HarvardHouston VABaylorTulaneBioElectronics Corporation
Partnerships and Collaboration

Partnerships supporting bioelectric research and commercialization.

Electrome's current foundation includes FDA-cleared devices developed and manufactured by BioElectronics Corporation. We welcome conversations with researchers, providers, retailers, pharmacies, rehabilitation clinics, health systems, and technology teams about future collaboration.

FDA-cleared therapeutic foundation
BioElectronics partnership
Research collaboration opportunities
Retail and pharmacy distribution
Provider workflow integration
Rehabilitation clinics
Health systems
Clinical evidence generation

Management Team

A short introduction to each leader. Complete biographies are on the team page.

Full leadership profiles
Erik A. Nilsen, PhD

Erik A. Nilsen, PhD

Co-Founder, CEO & CTO

Erik A. Nilsen, PhD, is a physicist and electrical engineer with a PhD in applied physics and advanced degrees in electrical engineering and mathematics.

Read full profile
Nev Zubcevik, D.O.

Nev Zubcevik, D.O.

Co-Founder & CMO

Dr. Nev Zubcevik is a board-certified physician and former Harvard Medical School faculty member and Medical Director at Spaulding Rehabilitation Hospital, with deep expertise in musculoskeletal medicine, traumatic brain injury, concussion, and non-pharmacologic pain management.

Read full profile
Danny Rubenstein

Danny Rubenstein

Chief Commercialization Officer

Danny Rubenstein is a commercial operator and strategic advisor with 40+ years of experience across consumer products, food, and emerging businesses.

Read full profile
Genevieve Johnson

Genevieve Johnson

Chief Sales Officer

Genevieve Johnson is building Electrome's sales organization and leads sales and distribution strategy across independent pharmacy, clinical and institutional accounts, and the PREVENT™ employer program.

Read full profile
Joe Oliveri

Joe Oliveri

Managing Director, Sports & Fitness

Joe Oliveri leads Electrome's sports and fitness channel end to end, with a primary focus on golf pro shops and golf retail, plus fitness centers, retail chains, distributors, agency partnerships, and military and public safety buyers.

Read full profile
Samir S. Awad, MD

Samir S. Awad, MD

Medical Director

Bioengineering graduate of the University of Pennsylvania with expertise in electrophysiology, then medicine and surgical critical care training (University of Michigan).

Read full profile
Shari O'Connor, PharmD, MBA

Shari O'Connor, PharmD, MBA

Scientific Advisor, Clinical Marketing & Sales Development

Shari O'Connor is a neuroimmunology expert with 30+ years advancing brain and immune-system therapies, with board-level credentials in Neurology, Immunology, Nutrition, and Pharmacogenomics.

Read full profile
Wanni Davis, PhD, MBA

Wanni Davis, PhD, MBA

Licensing Advisor

Wanni Davis is a biotech strategist with 15+ years spanning translational science, venture development, and commercialization.

Read full profile
Careers

Join the team building the future of bioelectric medicine.

We are not listing specific openings right now. If you think you would be a good fit for a small team building drug-free bioelectric therapies, we would like to hear from you.

Who We Work With
ProvidersRetailersResearchersStrategic PartnersPharmaciesRehabilitation ClinicsHealth Systems
Next steps

Invest or partner with Electrome.

Investors can request materials. Providers, retailers, researchers, and health systems can explore partnership areas.

Appearance